Related Experiment Video
Updated: Jun 4, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
SurvJamda: an R package to predict patients' survival and risk assessment using joint analysis of microarray gene
1Swiss Institute for Experimental Cancer Research (ISREC), Swiss Federal Institute of Technology (EPFL), School of Life Sciences (SV) and Swiss Institute of Bioinformatics, EPFL SV ISREC, Station 15, 1015 Lausanne, Switzerland. hyasrebi@yahoo.com
Unlabelled:
SurvJamda (Survival prediction by joint analysis of microarray data) is an R package that utilizes joint analysis of microarray gene expression data to predict patients' survival and risk assessment. Joint analysis can be performed by merging datasets or meta-analysis to increase the sample size and to improve survival prognosis. The prognosis performance derived from the combined datasets can be assessed to determine which feature selection approach, joint analysis method and bias estimation provide the most robust prognosis for a given set of datasets.
Availability:
The survJamda package is available at the Comprehensive R Archive Network, http://cran.r-project.org.
Contact:
hyasrebi@yahoo.com.
Related Concept Videos
Cancer Survival Analysis
Assumptions of Survival Analysis
Comparing the Survival Analysis of Two or More Groups
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Statistical Software for Data Analysis and Clinical Trials
Kaplan-Meier Approach

